Cargando…

Functions and mechanisms of N6-methyladenosine in prostate cancer

Prostate cancer (PCa) has long been a major public health problem affecting men worldwide. Even with treatment, it can develop into castration-resistant PCa. With the continuous advancement in epigenetics, researchers have explored N6-methyladenosine (m(6)A) in search of a more effective and lasting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Hongyuan, Feng, Yanyan, Wu, Junjie, Zhu, Lijie, Mi, Yuanyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364137/ https://www.ncbi.nlm.nih.gov/pubmed/35856412 http://dx.doi.org/10.3892/mmr.2022.12796

Ejemplares similares

Mechanism of RNA modification N6-methyladenosine in human cancer
por: Zhou, Zijian, et al.
Publicado: (2020)

Functions of N6-methyladenosine and its role in cancer
por: He, Liuer, et al.
Publicado: (2019)

Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy
por: He, Jiayi, et al.
Publicado: (2023)

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

Insights into N6-methyladenosine and programmed cell death in cancer
por: Liu, Li, et al.
Publicado: (2022)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

Mechanisms of RNA N(6)-Methyladenosine in Hepatocellular Carcinoma: From the Perspectives of Etiology
por: Lu, Jiahua, et al.
Publicado: (2020)

N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer
por: Ma, Mingyang, et al.
Publicado: (2022)

Roles of N(6)-methyladenosine (m(6)A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
por: Chen, Jiahua, et al.
Publicado: (2022)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

The interplay between N6-methyladenosine and precancerous liver disease: molecular functions and mechanisms
por: Lv, Zhihua, et al.
Publicado: (2023)

N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer
por: Wu, Qunying, et al.
Publicado: (2021)

Upregulation of COPB2 Promotes Prostate Cancer Proliferation and Invasion Through the MAPK/TGF-β Signaling Pathway
por: Feng, Yanyan, et al.
Publicado: (2022)

N(6)‐methyladenosine Steers RNA Metabolism and Regulation in Cancer
por: Dong, Shenghua, et al.
Publicado: (2021)

Dual effects of N(6)-methyladenosine on cancer progression and immunotherapy
por: Li, Hui, et al.
Publicado: (2021)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

The role of RNA N(6)-methyladenosine methyltransferase in cancers
por: Huang, Jiali, et al.
Publicado: (2021)

N(6)-methyladenosine (m(6)A) in pancreatic cancer: Regulatory mechanisms and future direction
por: Li, Jian, et al.
Publicado: (2021)

N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
por: Huang, Wei, et al.
Publicado: (2021)

N6-methyladenosine links RNA metabolism to cancer progression
por: Dai, Dongjun, et al.
Publicado: (2018)

Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk
por: Wan, Hongyuan, et al.
Publicado: (2022)

The roles of RNA N(6)-methyladenosine in esophageal cancer
por: Teng, Chuan, et al.
Publicado: (2022)

The emerging role of RNA N6-methyladenosine methylation in breast cancer
por: Zheng, Fangchao, et al.
Publicado: (2021)

Landscape of N(6)-Methyladenosine Modification Patterns in Human Ameloblastoma
por: Niu, Xing, et al.
Publicado: (2020)

The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022)

Association of N6-methyladenosine with viruses and related diseases
por: Wu, Fang, et al.
Publicado: (2019)

N6-methyladenosine methylation in kidney injury
por: Wang, Qimeng, et al.
Publicado: (2023)

The potential role of RNA N6-methyladenosine in Cancer progression
por: Wang, Tianyi, et al.
Publicado: (2020)

Roles and implications of mRNA N(6) ‐methyladenosine in cancer
por: Zeng, Lingxing, et al.
Publicado: (2023)

Novel insights into the interaction between N6-methyladenosine modification and circular RNA
por: Xu, Tao, et al.
Publicado: (2022)

N6‐methyladenosine regulatory machinery in plants: composition, function and evolution
por: Yue, Hong, et al.
Publicado: (2019)

Functions of RNA N(6)-methyladenosine modification in acute myeloid leukemia
por: Zheng, Xue, et al.
Publicado: (2021)

Function and clinical significance of N6-methyladenosine in digestive system tumours
por: Huang, Junchao, et al.
Publicado: (2021)

N(6)-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development
por: Niu, Yi, et al.
Publicado: (2018)

N(6)-Methyladenosine RNA-Binding Protein YTHDF1 in Gastrointestinal Cancers: Function, Molecular Mechanism and Clinical Implication
por: Chen, Danyu, et al.
Publicado: (2022)

The Role of N(6)-Methyladenosine in Inflammatory Diseases
por: Xu, Haojun, et al.
Publicado: (2022)

N(6)-methyladenosine (m(6)A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications
por: Hu, Bin-bin, et al.
Publicado: (2019)

RNA N (6)-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications
por: Dang, Qin, et al.
Publicado: (2021)

The Mechanism and Role of N(6)-Methyladenosine (m(6)A) Modification in Atherosclerosis and Atherosclerotic Diseases
por: Tan, Quandan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dml4j2aj63ann2rrqeac1auc1q